About: Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 05 January 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2019 (fr) artículu científicu espublizáu en xineru de 2019 (ast) scientific article published on 05 January 2019 (en) наукова стаття, опублікована 5 січня 2019 (uk)
publication date	wds:Q93369070-EA843968-389E-4E26-89DE-397238293502
publication date	2019-01-05 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q93369070-74BD877C-2353-4602-8B8F-30DE18631D0D
language of work or name	English
author name string	wds:Q93369070-2E11D24B-A1EA-4122-8A54-365430B29279 wds:Q93369070-4409B4EE-6ABB-4F14-A0C7-39EB9C320A14 wds:Q93369070-7035D1F9-BF97-486E-8CDF-B71D6D0DAAF4 wds:Q93369070-7C94BF17-9552-42F6-817F-16916DC6E6F3 wds:Q93369070-A1E635F5-8977-43B2-9849-8F2E6596DC71 wds:Q93369070-CAFDC10F-5120-45F5-9339-2BBC02AFB8D9 wds:Q93369070-F3AEA182-E492-48F7-AC99-F79824EECC9F wds:Q93369070-FDF9F9AB-0521-40E1-A02F-9CB7AE7D6BB0
author name string	Kuan-Yu Chen Ching-Yao Yang James Chih-Hsin Yang Jin-Shing Chen Chia-Lin Hsu Jih-Hsiang Lee Chao-Chi Ho Wei-Yu Liao
rdfs:label	Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations (en) Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations (nl)
skos:prefLabel	Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations (en) Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations (nl)
name	Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations (en) Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations (nl)
author	wds:Q93369070-0012561B-720A-4DF8-BC0B-534573698387 wds:Q93369070-7F677418-5BBB-41B3-8164-9250B51D4B16 wds:Q93369070-BB239DF0-450D-4147-86FF-40FDA70B2F9A wds:Q93369070-CCEAB2FC-6DF1-46D4-8678-BA4CCAAE3CF0
author	Chong-Jen Yu Jin-Yuan Shih Zhong-Zhe Lin Yen-Ting Lin
title	wds:Q93369070-29CDD311-4F04-4406-BC5F-5BE450AF8443
title	Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations (en)
page(s)	wds:Q93369070-B08E574B-108E-449F-AACC-27A13A20581D
page(s)	2887-2896
instance of	wds:Q93369070-33C65F23-D5C6-4A8C-AE2C-701C961004D8
instance of	scholarly article
PubMed ID	wds:Q93369070-485A5FCE-74B2-42F5-8F80-50A14DFA9B40
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30485437
PubMed ID	30485437
published in	wds:Q93369070-CABBD47B-E761-4CFD-9609-81275EACB6D2
published in	International Journal of Cancer
issue	wds:Q93369070-5ABB8B30-5026-4623-9F33-38FBAA8F3D40
volume	wds:Q93369070-13401E26-3753-48F0-9D9F-797D46C5AC60
issue	11
volume	144
DOI	wds:Q93369070-822CB0D9-61B5-448E-B3A1-CAF15E841E46
DOI	http://dx.doi.org/10.1002/IJC.32025
DOI	10.1002/IJC.32025
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q93369070
is cites work of	First-line afatinib for the treatment of mutation-positive non-small-cell lung cancer in the 'real-world' clinical setting Advances in targeting acquired resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors FGFR1 Induces Acquired Resistance Against Gefitinib By Activating AKT/mTOR Pathway In NSCLC
is cites work of	wds:Q64115858-B66D69A2-8382-4DA3-95E4-D6784D65A08B wds:Q97538345-54C9867F-B146-4AA2-90EC-81EDF95DB0CC wds:Q91828605-CBE7AD6F-92B3-4166-B977-C78CCCE9256E

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software